aDepartment of Applied Clinical Sciences and Biotechnology, University of L’Aquila
bDepartment MeSVA, University of L’Aquila, L’Aquila, Italy
cDepartment of Molecular Immunology, Virology, and Medical Genetics, The Ohio State University, Columbus, Ohio, USA
dPreclinical Development Department, Menarini Ricerche, Firenze, Italy
*Francesco Marampon and Giovanni L. Gravina contributed equally to the writing of this article.
Correspondence to Francesco Marampon, Department of Applied Clinical Sciences and Biotechnology, University of L’Aquila, Via Vetoio, Coppito 2, L’Aquila, Italy. E-mail: [email protected]
Received 14 February, 2013
Revised 24 April, 2013
Accepted 23 May, 2013
